Limited evidence

Live dashboards and rankings are open; unlock source trails, evidence timestamps, archive access, workflow tools, and alerts.

Weekly Briefing

Weekly Briefing

Storylines + notable one-off Signals, with verification trails and workflows in the app.

Live2026-W05Week 2026-01-26 → 2026-02-01Generated 2026-02-02 06:03 UTC

No investment advice. Research signals and sources only. EarlyNarratives provides informational signals derived from public sources. It does not provide financial, legal, or tax advice.

Archive
2026-W05
2026-01-26 → 2026-02-01
2026-W04
2026-01-19 → 2026-01-25
2026-W03
2026-01-12 → 2026-01-18
2026-W02
2026-01-05 → 2026-01-11
2026-W01
2025-12-29 → 2026-01-04
Storylines
Storyline

Nanogram-scale MS benchmarks: isotope ratios and reproducible CZE-MS

Two bioRxiv method preprints report benchmarks aimed at extending proteomics-compatible MS into scarce-sample and higher-robustness regimes. One integrates Fourier Transform Isotopic Ratio Mass Spectrometry (FT IsoR MS) with single-cell-style preparation and reports reliable relative δ13C measurements from as few as ~50 HeLa cells (<10 ng protein), while noting that <10 cells are not statistically robust. The other presents an ~170-run CZE-MS dataset to support qualitative and quantitative reproducibility for multi-level proteomics (bottom-up, top-down, native) across E. coli, HeLa, and human plasma, and reports native proteomics detection of hundreds of complexoforms up to 800 kDa while con

Updated n/aActive span n/a
Live
ScoreOverall signal strength in the selected window; higher means more evidence/consistency, not a prediction.Learn more
-
Momentum 24hChange in signal activity over the last 24 hours; higher means accelerating attention, not performance.Learn more
-
PostsCount of items included in the signal cluster for this window.Learn more
-
Notable one-off signals
Signal

Preprints benchmark nanogram-scale isotope-ratio MS and reproducible CZE-MS proteomics

Two bioRxiv method preprints report benchmarks aimed at expanding proteomics-compatible MS into scarce-sample and higher-robustness regimes.

Updated 4d agoActive span 12h
Limited history
ScoreOverall signal strength in the selected window; higher means more evidence/consistency, not a prediction.Learn more
0.7
Momentum 24hChange in signal activity over the last 24 hours; higher means accelerating attention, not performance.Learn more
2
PostsCount of items included in the signal cluster for this window.Learn more
2
Details
1 publishers2 posts1 platformsTop source 100%
Seed
proteomicsMass Spectrometry
OriginsDistinct origin sources contributing to this signal; higher means broader origin coverage.Learn more
1
PublishersDistinct publishers/accounts observed; higher means broader publisher participation.Learn more
1
Dup ratioShare of near-duplicate items in the cluster; higher can indicate repetition or amplification.Learn more
0%
Top origin sharePortion of items from the top origin; higher means more concentration.Learn more
100%
SourcesNumber of source types represented (e.g., news vs social).Learn more
1
Maturity scoreHeuristic confidence score derived from breadth and consistency indicators.Learn more
0.25
Why now
  • Both items are newly posted bioRxiv preprints with explicit sensitivity/reproducibility benchmarks
  • Single-cell-style prep and nanogram inputs align with increasing limited-sample study designs
  • A large (~170-run) series directly addresses robustness concerns for CZE-MS workflows
Evidence
2 sources locked
Unlock evidence trails

Unlock source trails, evidence timestamps, archive access, and workflow tools.